Safety profile of somavaratan (VRS-317), a novel long-acting rhGH fusion protein, in pre-pubertal children with growth hormone deficiency (GHD)

Authors
Category Primary study
JournalGrowth Hormone and IGF Research
Year 2016
This article has no abstract
Epistemonikos ID: c93a2d5c1522b33058f7854c9fe935fc18c0173f
First added on: Feb 08, 2025